T1	Participants 74 105	patients with allergic rhinitis
T2	Participants 0 70	Nasal eosinophilia and serum soluble intercellular adhesion molecule 1
T3	Participants 685 826	In this single-center, randomized, double-blind, placebo-controlled, crossover, two-arm study, 40 patients with persistent AR were randomized
